Blood Draw Study for Liver Transplant Patients
This trial is active, not recruiting.
|Condition||liver transplant recipients|
|Sponsor||Baylor Research Institute|
|Start date||October 2002|
|End date||November 2014|
|Trial size||200 participants|
|Trial identifier||NCT01525797, 002-197|
The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.
Identify signatures predictive of graft rejection or tolerance.
time frame: 2 years
Male or female participants from 17 years up to 65 years old.
Inclusion Criteria: - Received a liver Transplant Exclusion Criteria: - Received Multiple Organ Transplant
|Official title||Immunomonitoring of Transplant Patients|
|Principal investigator||Goran Klintmalm, MD|
|Description||The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.|
Call for more information